Request Trial
shutterstock_306121976_jpstock
JPstock / Shutterstock.com
3 April 2019Biotech

English court claims jurisdiction in Unilever antibody dispute

The English High Court will hear a patent dispute between a subsidiary of biopharmaceutical company Sanofi and British-Dutch consumer goods brand Unilever.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
Masimo keeps $634m smartwatch award and moves to appeal
21 July 2026   Now a Danaher subsidiary, the company is contesting a number of orders after a California court finalised several aspects of the high-profile dispute.
Biotech
Arbutus takes Comirnaty LNP patent fight to Canada and UPC
20 July 2026   The biotech company has launched a trio of lawsuits against two vaccine makers, while announcing receipt of a $178 million sum from Moderna under a previous deal.
Biotech
Illumina ordered to recall products after German patent ruling
16 July 2026   A Munich court ruled that Illumina infringed a rival’s DNA sequencing patents, handing the challenger an early victory in a dispute that is playing out across Europe and the US.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Why is 2026 already a record year for M&A activity?
17 July 2026
Biotech
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

More features

USPTO director steps into Sun Pharma’s PTAB-ITC clash
USPTO appoints new acting commissioner for patents
European court strikes down hearing aid sensor patent
Where Big Pharma is betting big in the M&A boom
Fish & Richardson adds AI and medical device specialist
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?
FisherBroyles and Hong Kong affiliate draft in senior partners